Actively Recruiting
Comparing oral fluconazole and itraconazole for treating resistant tinea corporis in adults aged 18-70
Led by Urooj Fatima · Updated on 2026-01-15
126
Participants Needed
1
Research Sites
2 weeks
Total Duration
AI-Summary
What This Trial Is About
Tinea corporis, also known as ringworm of the body, is a fungal skin infection that can be hard to treat when it does not respond to creams or other medicines. This research evaluates two oral antifungal drugs, fluconazole and itraconazole, in adults aged 18 to 70 years with resistant tinea corporis lasting at least six months. The study aims to find which medication leads to complete skin healing without redness, scaling, itching, or visible lesions after four weeks of treatment. Participants will be randomly assigned to one of two groups receiving oral antifungal treatment at the Dermatology Department of CDA Hospital, Islamabad. One group will take itraconazole 200 mg daily for four weeks, while the other group will take fluconazole 150 mg every other day for four weeks. The study uses a single-blind design, meaning participants will not know which medication they receive. Clinical outcomes will be assessed at the end of treatment using standardized severity scales. During the study, doctors will evaluate symptom severity with the Dermatophyte Severity Scale and participants will report their itching levels using a visual analog scale. The main outcome is the number of participants achieving complete clinical resolution four weeks after starting treatment. The trial will last six months from approval, with data analyzed to compare the effectiveness of the two drugs. Results will help guide treatment choices for resistant tinea corporis in Pakistan and similar regions.
CONDITIONS
Brief Title
Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis
Research Team
U
Urooj Fatima, MBBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here